Immunocytochemical detection of matrix metalloproteinase expression in prostate cancer

In Vivo

Volumn 15, Issue 1, 2001, Pages 65-70

  Bodey, B ^a   Bodey B , Jr ^a   Siegel, S E ^a   Kaiser, H E ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Dedifferentiation; Extracellular matrix (ECM); Invasion; Matrix metalloproteinases (MMPs); Metastasis; Prostatic carcinoma; Tumor tissue progression

Indexed keywords

ALKALINE PHOSPHATASE; ANTIBODY CONJUGATE; COLLAGENASE 3; CYTOKINE; GELATINASE A; GELATINASE B; GROWTH FACTOR; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; MONOCLONAL ANTIBODY; STROMELYSIN; STROMELYSIN 2;

ARTICLE; BLOOD VESSEL; CANCER GROWTH; CANCER INVASION; CARCINOMA IN SITU; CELL MIGRATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; LUNG ADENOCARCINOMA; METASTASIS; MICROVASCULATURE; PROSTATE CANCER; PROSTATE CARCINOMA; PROTEIN EXPRESSION; SEQUENCE HOMOLOGY; STAINING; STROMA CELL;

EID: 0035086449     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Adenocarcinoma of the prostate
2. Purification and properties of a gelatin-specific neutral protease from human skin
3. Cleavage of type VII collagen by interstitial collagenase and type IV collagenase (gelatinase) derived from human skin
4. Cleavage specificity of human skin type IV collagenase (gelatinase). Identification of cleavage sites in type I gelatin, with confirmation using synthetic peptides
5. Cleavage of collagen type X by human synovial collagenase and neutrophil elastase
6. Differential susceptibility of type X collagen to cleavage by two mammalian interstitial collagenases and 72-kDa type IV collagenase
7. Human 92- and 72-kilodalton type IV collagenases are elastases
8. Expression of a metalloproteinase that degrades native type V collagen and denatured collagens by cultured human alveolar macrophages
9. A 92 kDa gelatinase (MMP-9) cleavage site in native type V collagen
10. Relation between substrate specificity and domain structure of 92-kDa type IV collagenase
11. Characteristics of 92 kDa type IV collagenase/gelatinase produced by granulocytic leukemia cells: Structure, expression of cDNA in E. coli and enzymic properties
12. The interglobular domain of cartilage aggrecan is cleaved by PUMP, gelatinases, and cathepsin B
13. Matrix metalloproteinases cleave at two distinct sites on human cartilage link protein
14. Identification of a stromelysin cleavage site within the interglobular domain of human aggrecan. Evidence for proteolysis at this site in vivo in human articular cartilage
15. Degradation of proteoglycan aggregate by a cartilage mettaloproteinase. Evidence for the involvement of stromelysin in the degradation of link protein heterogeneity in situ
16. Sites of stromelysin cleavage in collagen types II, IX, X, and XI of cartilage
17. Nonenzymatic glycation of type IV collagen and matrix metalloproteinase susceptibility
18. Matrix metalloproteinase-3 (stromelysin-1). Identification as the cartilage acid metalloprotease and effect of pH on catalytic properties and calcium affinity
19. Interaction of human rheumatoid synovial collagenase (matrix metalloproteinase 1) and stromelysin (matrix metalloproteinase 3) with human α2-macroglobulin and chicken ovostatin. Binding kinetics and identification of matrix metalloproteinase cleavage sites
20. Kinetics and physiologic relevance of the inactivation of alpha 1-proteinase inhibitor, alpha 1-antichymotrypsin, and antithrombin III by matrix metalloproteinases-1 (tissue collagenase), -2 (72-kDa gelatinase/type IV collagenase), and -3 (stromelysin)
21. A semicontinuous, high-performance liquid chromatography-based assay for stromelysin
22. Matrix metalloproteinases degrade insulin-like growth factor-binding protein-1 in dermal fibroblast cultures
23. Sites of nidogen cleavage by proteases involved in tissue homeostasis and remodelling
24. Limited cleavage of extracellular matrix protein BM-40 by matrix metalloproteinases increases its affinity for collagens
25. Different susceptibilities of fibulin-1 and fibulin-2 to cleavage by matrix metalloproteinases and other tissue proteases
26. Degradation of cross-linked fibrin by matrix metalloproteinase 3 (stromelysin 1): Hydrolysis of the gGly404-Ala405 peptide bond
27. Degradation of vitronectin by matrix metalloproteinases-1, -2, -3, -7, and -9
28. Direct activation of human neutrophil procollagenase by recombinant stromelysin
29. Biochemical characterization of human collagenase-3
30. Stepwise activation mechanisms of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and 4-aminophenyl)mercuric acetate
31. Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9
32. Mechanisms of activation of tissue procollagenase by matrix metalloproteinase 3 (stromelysin)
33. Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme
34. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage
35. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage
36. Immunophenotyping of childhood astrocytomas with a library of monoclonal antibodies
37. Immunoalkaline phosphatase cytochemistry
38. Diagnostic significance of levamisole-resistant alkaline phosphatase in cytochemistry and immunocytochemistry
39. The avidin-biotin reaction as an universal amplification system in immunoassays
40. Introduction to avidin-biotin technology
41. Prevention of nonspecific binding of avidin
42. The biotin-(strept)avidin system: Principles and applications in biotechnology
43. Location of 72-kd metalloproteinase (type IV collagenase) in untreated prostatic adenocarcinoma
44. Immunohistochemical evaluation of type IV collagenase (72-kd metalloproteinase) in prostatic intraepithelial neoplasia
45. Immunohistochemical studies of activated matrix metalloproteinase-2 (MMP-2a) expression in human prostate cancer
46. Evidence for increased activated metalloproteinase 2 (MMP-2a) expression associated with human prostate cancer progression
47. Secretion of matrix metalloproteinases and their inhibitors (tissue inhibitor of metalloproteinases) by human prostate in explant cultures: Reduced tissue inhibitor of metallooproteinase secretion by malignant tissues
48. In situ hybridization studies of metalloproteinases 2 and 9 and TIMP-1 and TIMP-1 and TIMP-2 expression in human prostate cancer
49. Expression of matrix metalloproteinase-7 and tissue inhibitor of metalloproteinase-1 in human prostate
50. Localization and quantification of mRNA for matrix metalloproteinase-2 (MMP-2) and tissue inhibitor of matrix metalloproteinase-2 (TIMP-2) in human benign and malignant prostatic tissue
51. Matrix metalloproteinase 9 expression in primary human prostatic adenocarcinoma and benign prostatic hyperplasia
52. Neuropeptides induce Mr 92,000 type IV collagenase (matrix metalloprotease-9) activity in human prostate cancer cell lines
53. Expression of the metalloproteinase matrilysin in DU-145 cells increases their invasive potential in severe combined immunodeficient mice
54. EGF induces the expression of matrilysin in the human prosstate adenocarcinoma cell line, LNCaP
55. Interleukin 10 (IL-10) inhibition of primary human prostate cell-induced angiogenesis: IL-10 stimulation of tissue inhibitor of metalloproteinase-1 and inhibition of matrix metalloproteinase (MMP)-2/MMP-9 secretion
56. Role of interleukin 10 and transforming growth factor betal in the angiogenesis and metastasis of human prostate primary tumor lines from orthotopic implants in severe combined immunodeficiency mice
57. Membrane type 1-matrix metalloproteinase (MT1-MMP) and MMP-2 immunolocalization in human prostate: Change in cellular localization associated with high-grade prostatic intraepithelial neoplasia